RESCAP iv, The placebo is identical with the IMP, but without active substance clinical trials

Preventing oxidative stress-induced ischemic injury and systemic inflammation complications during and after invasive cardiac surgery with alkaline phosphatase (APPIRED III)

This study looks at a new drug (RESCAP) to reduce serious problems like kidney damage and inflammation that can happen after complex heart surgery. It compares the drug to a dummy treatment to see if it helps patients recover better.